Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/09/sgrx-stock-dips-as-bit-origin-rebrands-to-sangrix.jpg
https://stockstotrade-nuxt-staging.stockstotrade-com-inc.workers.dev/

SGRX Stock Dips As Bit Origin Rebrands To Sangrix

TIM BOHEN•UPDATED SEP. 4, 2026, 4:17 PM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

SANGRIX Inc Cl A Ord faces pressure as regulatory probe intensifies, and stocks have been trading down by -0.99 percent

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading SGRX

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

What Traders Need To Know

  • Bit Origin is rebranding to Sangrix, with its Class A ordinary shares set to begin trading on Nasdaq under the new name and ticker SGRX on 2026/09/04.
  • The change means existing Bit Origin shareholders will see their holdings continue on Nasdaq under the new corporate name Sangrix and the updated ticker symbol SGRX.
  • The timing of the rebrand and ticker switch to 2026/09/04 positions Sangrix for a fresh identity in the public markets heading into that trading session.

Candlestick Chart

Weekly Update Aug 31 – Sep 04, 2026: On Friday, September 04, 2026 SANGRIX Inc Cl A Ord stock [NASDAQ: SGRX] is trending down by -0.99%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Finance industry expert:

Analyst sentiment – negative

Sangrix (SGRX) currently sits as a micro-cap, pre-revenue financial platform with negligible trailing revenue (~$39k) and deeply negative retained earnings of ~$88m, implying a long history of losses and dilution. Despite this, the balance sheet is clean: virtually no long-term debt, current liabilities of only ~$0.37m, and working capital of ~$3.16m. Enterprise value of ~$1.78m and price-to-sales of ~48.9 highlight a valuation driven purely by optionality rather than fundamentals.

Technically, SGRX shows a clear short-term downtrend: the weekly sequence from 2.78 to 2.18 reflects persistent lower highs and lower lows, with accelerating intraday volatility as price broke below 2.40 support and briefly tested near 2.02 before rebounding. Recent 5-minute candles (thin volume, wide spreads) indicate poor liquidity and high slippage risk. For tactical trading, 2.00 is the critical actionable level: below it, downside can accelerate; above 2.40, a short-covering bounce toward 2.70 is likely.

More Breaking News

The recent rebranding from Bit Origin to Sangrix and Nasdaq relaunch under SGRX is a short-term headline catalyst but does not change the weak economic base. Versus broader Finance and Capital Markets benchmarks, SGRX massively underperforms on ROIC (-26.2%), scale, and earnings visibility, and screens as a speculative vehicle only. Base case: trading range 2.00–2.70, with resistance near 2.70 and support at 2.00; risk-reward skew remains unfavorable for institutional capital.

Quick Financial Overview

SANGRIX Inc Cl A Ord, now trading under ticker SGRX, comes into this rebrand after a sharp price slide. Weekly data show the stock fading from about $2.78 to roughly $2.18 over a few sessions, so the market is already in a downtrend. On 2026/09/04 specifically, SGRX sold off from the low $2.30s toward $2.02 before a modest bounce, confirming selling pressure around the first day with the new ticker.

The intraday 5‑minute chart shows heavy volatility during premarket and early hours, with prints above $5 collapsing into the $2–$3 range. That kind of range usually signals thin liquidity and fast-moving orders, not steady accumulation. Into the close, SGRX held near $2.18 after testing lows near $2.00, setting a short-term support band but still well below the morning highs.

On the fundamentals, Sangrix is tiny. Revenue is about $39,495, with a price-to-sales near 48.88, so traders are paying a steep multiple for very limited sales. Book value per share is 4.69 with price-to-book around 0.5, which implies the stock trades at a discount to its balance sheet, but returns on capital are weak with a recent ROIC near -26.23. The balance sheet lists total assets of about $3.54M and equity around $3.90M, supported mainly by paid-in capital, while retained earnings are deeply negative. Sangrix reports only five employees, underlining how early-stage and speculative SGRX remains.

Conclusion

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders